+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Organ Transplant Diagnostics Market by Test Type (Genetic, Histocompatibility, Molecular), Organ Type (Heart, Kidney, Liver), Technology, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925160
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The organ transplant diagnostics market is advancing rapidly, reflecting growing clinical demand, evolving technological standards, and intensifying global competition. Stakeholders are navigating a landscape influenced by innovation, regulatory change, and shifting procurement dynamics.

Market Snapshot: Organ Transplant Diagnostics Market Overview

The organ transplant diagnostics market grew from USD 4.46 billion in 2024 to USD 4.80 billion in 2025. With an expected CAGR of 7.50%, the market is projected to reach USD 6.89 billion by 2030.

Scope & Segmentation of the Organ Transplant Diagnostics Market

This comprehensive report analyzes the dynamics, opportunities, and challenges across multiple segments and regions:

  • Test Types: Genetic testing (DNA sequencing, SNP genotyping), Histocompatibility (crossmatching, HLA typing), Molecular diagnostics (next generation sequencing, PCR), Serological methods (ELISA, flow cytometry).
  • Organ Types: Heart, kidney (deceased and living donor differentiation), liver (deceased and living donor), lung, and pancreas transplantation.
  • Technologies: ELISA formats (competitive and sandwich), flow cytometry platforms (cell sorting, immunophenotyping), microarray systems (expression arrays, SNP arrays), next generation sequencing (targeted and whole genome workflows), and PCR (digital, real-time).
  • Applications: Posttransplant monitoring (infection screening, rejection monitoring) and pretransplant matching (crossmatch testing, HLA matching).
  • End Users: Diagnostic centers (hospital and independent labs), hospitals (general and transplant centers), research laboratories.
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning major and emerging economies), Asia-Pacific (notably China, India, Japan, Australia, South Korea, and key Southeast Asian markets).
  • Key Companies: Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, bioMérieux SA, QIAGEN N.V., PerkinElmer Inc., DiaSorin S.p.A., and Bio-Rad Laboratories Inc.

Key Takeaways for Senior Decision-Makers

  • Molecular diagnostics and next-generation sequencing are redefining transplant compatibility assessment and post-procedure monitoring, shaping clinical protocols and stakeholder strategies.
  • AI and machine learning are being incorporated into interpretive workflows, offering more accurate risk prediction and faster turnaround for complex genomic data.
  • Regulatory adjustment is ongoing, with adaptive approval pathways and real-world evidence initiatives enhancing the viability of novel diagnostic assays and facilitating faster market entry.
  • Supply chain strategies are increasingly important, driven by shifts in procurement practices, localization of manufacturing, and risk mitigation in response to market traits.
  • Collaborative arrangements among diagnostic developers, healthcare providers, and research institutions are supporting assay validation and the standardization of emerging methodologies.

Tariff Impact: Navigating New Cost Structures in the U.S.

Recently introduced U.S. tariffs on imported diagnostic equipment and reagents have raised input costs for laboratories and healthcare networks. As a result, organizations are re-evaluating supplier arrangements, exploring alternatives, and prioritizing domestic manufacturing for critical assay components. To absorb cost pressures, market players are investing in automation, optimizing assay efficiency, and consolidating procurement to secure favorable pricing terms. Strategic resilience in navigating tariff effects rests on cohesive approaches linking procurement, compliance, and technology adoption.

Methodology & Data Sources

This research relies on primary interviews with transplant immunologists, laboratory directors, and industry analysts, complemented by secondary review of published literature, company filings, and regulatory guidance. The methodology integrates qualitative thematic analysis, segmentation mapping, and expert peer validation to ensure robust, actionable insights for market participants.

Why This Report Matters

  • Equips decision-makers with in-depth understanding of critical technology trends, regulatory frameworks, and segment dynamics shaping near- and long-term growth.
  • Highlights practical strategies for mitigating supply chain and tariff risks while sustaining innovation and competitive advantage in transplant diagnostics.
  • Supports informed investment decisions by profiling leading market participants and clarifying the relevance of emerging applications and platforms.

Conclusion

With dynamic regulatory, technological, and market shifts in play, the organ transplant diagnostics landscape demands agile, informed leadership. This report delivers clear, actionable insights to help stakeholders achieve clinical and commercial success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of donor-derived cell-free DNA assays to enhance early rejection detection in kidney transplant recipients
5.2. Adoption of multiplex immunoassay panels to predict acute rejection and tailor immunosuppressive regimens for liver transplant patients
5.3. Development of AI-driven imaging algorithms for quantifying graft perfusion and identifying early signs of transplant vasculopathy
5.4. Emergence of rapid point-of-care gene expression profiling to monitor immune status in heart transplant recipients
5.5. Expansion of donor organ viability assessment using normothermic machine perfusion biomarkers in lung transplantation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Organ Transplant Diagnostics Market, by Test Type
8.1. Introduction
8.2. Genetic
8.2.1. Dna Sequencing
8.2.2. SnP Genotyping
8.3. Histocompatibility
8.3.1. Crossmatching
8.3.2. Hla Typing
8.4. Molecular
8.4.1. Next Generation Sequencing
8.4.2. Pcr
8.5. Serological
8.5.1. Elisa
8.5.2. Flow Cytometry
9. Organ Transplant Diagnostics Market, by Organ Type
9.1. Introduction
9.2. Heart
9.3. Kidney
9.3.1. Deceased Donor
9.3.2. Living Donor
9.4. Liver
9.4.1. Deceased Donor
9.4.2. Living Donor
9.5. Lung
9.6. Pancreas
10. Organ Transplant Diagnostics Market, by Technology
10.1. Introduction
10.2. Elisa
10.2.1. Competitive Elisa
10.2.2. Sandwich Elisa
10.3. Flow Cytometry
10.3.1. Cell Sorting
10.3.2. Immunophenotyping
10.4. Microarray
10.4.1. Expression Arrays
10.4.2. SnP Arrays
10.5. Next Generation Sequencing
10.5.1. Targeted Sequencing
10.5.2. Whole Genome Sequencing
10.6. Pcr
10.6.1. Digital Pcr
10.6.2. Real Time Pcr
11. Organ Transplant Diagnostics Market, by Application
11.1. Introduction
11.2. Posttransplant Monitoring
11.2.1. Infection Screening
11.2.2. Rejection Monitoring
11.3. Pretransplant Matching
11.3.1. Crossmatch Testing
11.3.2. Hla Matching
12. Organ Transplant Diagnostics Market, by End User
12.1. Introduction
12.2. Diagnostic Centers
12.2.1. Hospital Labs
12.2.2. Independent Labs
12.3. Hospitals
12.3.1. General Hospitals
12.3.2. Transplant Centers
12.4. Research Laboratories
13. Americas Organ Transplant Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Organ Transplant Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Organ Transplant Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Roche Holding AG
16.3.2. Abbott Laboratories
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Siemens Healthineers AG
16.3.5. Danaher Corporation
16.3.6. bioMérieux SA
16.3.7. QIAGEN N.V.
16.3.8. PerkinElmer, Inc.
16.3.9. DiaSorin S.p.A.
16.3.10. Bio-Rad Laboratories, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ORGAN TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ORGAN TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ORGAN TRANSPLANT DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. ORGAN TRANSPLANT DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. ORGAN TRANSPLANT DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. ORGAN TRANSPLANT DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SNP GENOTYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SNP GENOTYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CROSSMATCHING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CROSSMATCHING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEART, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEART, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DECEASED DONOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DECEASED DONOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVING DONOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVING DONOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DECEASED DONOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DECEASED DONOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVING DONOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVING DONOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LUNG, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LUNG, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PANCREAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CELL SORTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CELL SORTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY IMMUNOPHENOTYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY IMMUNOPHENOTYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY EXPRESSION ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY EXPRESSION ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SNP ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTION SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTION SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REJECTION MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REJECTION MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CROSSMATCH TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CROSSMATCH TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA MATCHING, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA MATCHING, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 231. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 232. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 233. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 234. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 235. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 236. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 237. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 238. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 239. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 240. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 241. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 242. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 243. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2024 (USD MILLION)
TABLE 244. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2025-2030 (USD MILLION)
TABLE 245. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2024 (USD MILLION)
TABLE 246. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2025-2030 (USD MILLION)
TABLE 247. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 250. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 251. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 252. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 253. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 254. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 255. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 256. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 257. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 258. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 259. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2024 (USD MILLION)
TABLE 262. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2025-2030 (USD MILLION)
TABLE 263. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2024 (USD MILLION)
TABLE 264. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2025-2030 (USD MILLION)
TABLE 265. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 268. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 269. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 270. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 272. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 273. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 274. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 275. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2024 (USD MILLION)
TABLE 276. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2025-2030 (USD MILLION)
TABLE 277. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 278. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 279. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2024 (USD MILLION)
TABLE 280. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2025-2030 (USD MILLION)
TABLE 281. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2024 (USD MILLION)
TABLE 282. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025-2030 (USD MILLION)
TABLE 283. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2024 (USD MILLION)
TABLE 284. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2025-2030 (USD MILLION)
TABLE 285. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2024 (USD MILLION)
TABLE 286. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2025-2030 (USD MILLION)
TABLE 287. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 290. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 291. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 292. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 293. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 294. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 295. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 296. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 297. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 298. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 299. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2024 (USD MILLION)
TABLE 302. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2025-2030 (USD MILLION)
TABLE 303. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2024 (USD MILLION)
TABLE 304. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2025-2030 (USD MILLION)
TABLE 305. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 308. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 309. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 310. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Organ Transplant Diagnostics market report include:
  • Roche Holding AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Danaher Corporation
  • bioMérieux SA
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories, Inc.

Table Information